A War on Two Fronts: Cancer Care in the Time of COVID-19
- PMID: 32219410
- PMCID: PMC7133056
- DOI: 10.7326/M20-1133
A War on Two Fronts: Cancer Care in the Time of COVID-19
Abstract
Initial reports suggest that COVID-19 can be particularly lethal in patients with cancer. This commentary discusses how to balance a delay in cancer diagnosis or treatment against the risk for a potential COVID-19 exposure, mitigate the risks for significant care disruptions associated with social distancing behaviors, and manage the appropriate allocation of limited health care resources in this unprecedented time of health care crisis.
Keywords: COVID-19; Cancer chemotherapy; Cancer treatment; Drug delivery system preparation; Health care; Health care providers; Hereditary nonpolyposis colorectal cancer; Patients; Prevention, policy, and public health; Respiratory system procedures.
Figures

Comment in
-
Lung Cancer Surgical Management During the Outbreak of Coronavirus Disease 2019.J Thorac Oncol. 2020 Jun;15(6):e81. doi: 10.1016/j.jtho.2020.03.027. Epub 2020 Apr 11. J Thorac Oncol. 2020. PMID: 32289517 Free PMC article. No abstract available.
References
-
- Ferguson NM, Laydon D, Nedjati-Gilani G, et al. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imperial College London. 16 March 2020. Accessed at www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news--wuhan-co.... on 17 March 2020.
-
- Di Marco F, Barbaro M. ‘It's like a war.' New York Times. 17 March 2020. Accessed at www.nytimes.com/2020/03/17/podcasts/the-daily/italy-coronavirus.html?sho.... on 19 March 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical